| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.083 | 0.005 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.006 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.007 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.008 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.009 |